Scandinavian ChemoTech: Zapping Cancer

Initiating Coverage

2023-03-15

08:00

Redeye initiates coverage of Scandinavian ChemoTech, a Swedish medtech company in early-stage commercialisation with its tumour-specific electroporation (TSE) treatment method for both humans and animal cancer patients. Scandinavian ChemoTech awaits case study data from superficial and deep-seated tumours, and we believe its technology has the potential to disrupt the cancer market.

SA

FE

Sebastian Andersson

Filip Einarsson

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.